SRZN / Surrozen, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Surrozen, Inc.
US ˙ NasdaqCM ˙ US86889P1093

Deler fremragende 11,486,707 shares
Insideraktier3.519.528 shares
Insider ejerskab30,64 %
Total Insiders28
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Se Højest rangerende aktier
Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Se Højest rangerende aktier
Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

1 ( )
352 out of 10986

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

4.054% ( )
50 out of 10856

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Surrozen, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet		 Dele
Justeret
Mitchell J Md Blutt 10% Owner - [10%] 0 0
Anna Berkenblit Director - [D] 35.129 2.342
Christopher Y Chai Director - [D] 35.129 2.342
Column Group Iii Gp, Lp 10% Owner - [10%] 1.361.485 1.361.485
Column Group Iii, Lp 10% Owner - [10%] 4.904.884 1.361.485
Column Group Iii-a, Lp 10% Owner - [10%] 4.904.884 1.361.485
Consonance Capital Management LP Director, 10% Owner - [D] [10%] 450.828 0
Consonance Capital Opportunity Fund Management LP Director, 10% Owner - [D] [10%] 0 128.900
Consonance Capman GP, LLC Director, 10% Owner - [D] [10%] 450.828 0
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet		 Dele
Justeret
Consonance Life Sciences 10% Owner - [10%] 1.885.000 0
Mary Haak-Frendscho Director - [D] 35.129 2.342
Christopher Haqq - 30.000 2.000
Joshua Cory House 0
Jennifer Jarrett - 30.000 2.000
Tim Kutzkey Director, 10% Owner - [D] [10%] 1.361.485 1.361.485
Yang Li Exec. Vice President, Research - [O] 14.425 14.425
Shao-Lee Lin Director - [D] 35.129 2.342
Kevin Harold Livingston 10% Owner - [10%] 1.885.000 0
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet		 Dele
Justeret
Craig C Parker Chief Executive Officer, Director - [D] [O] 8.577 8.577
Mace Rothenberg Director - [D] 35.129 2.342
Donald J Santel - 30.000 2.000
Benny Soffer 10% Owner - [10%] 1.885.000 0
Gad Soffer 0
TCG Crossover GP II, LLC 10% Owner - [10%] 736.547 736.547
Geertrui Vanhove Chief Medical Officer - [O] 32.412 2.161
David J Woodhouse Director - [D] 35.129 2.342
Charles O Williams Chief Operating Officer - [O] 12.982 12.982
Wen-Chen Yeh Chief Scientific Officer - [O] 27.216 1.814

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i SRZN / Surrozen, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier		 Rapporteret
Pris		 Justeret
Aktier		 Justeret
Pris		 Omkostningsgrundlag dage til
Maks		 Pris kl
Maks		 Maks
Fortjeneste ($)		 Maks. afkast (%)
2026-03-24 TCG Crossover GP II, LLC 53.329 24,6931 53.329 24,6931 1.316.858 38 33.6000 474.996 36,07
2026-03-24 TCG Crossover GP II, LLC 53.329 24,6931 53.329 24,6931 1.316.858
2026-03-23 TCG Crossover GP II, LLC 7.611 24,8999 7.611 24,8999 189.513
2026-03-23 TCG Crossover GP II, LLC 7.612 24,8999 7.612 24,8999 189.538
2026-03-16 TCG Crossover GP II, LLC 595 24,9857 595 24,9857 14.866
2026-03-16 TCG Crossover GP II, LLC 595 24,9857 595 24,9857 14.866
2026-03-13 TCG Crossover GP II, LLC 17.716 24,8769 17.716 24,8769 440.719
2026-03-13 TCG Crossover GP II, LLC 17.717 24,8769 17.717 24,8769 440.744
2026-03-12 TCG Crossover GP II, LLC 6.187 24,9851 6.187 24,9851 154.583

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SRZN / Surrozen, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i SRZN / Surrozen, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier		 Rapporteret
Pris		 Justeret
Aktier		 Justeret
Pris		 Omkostningsgrundlag dage til
Min		 Pris kl
Min		 Max tab
Undgået ($)		 Max tab
Undgået (%)
2026-01-05 Li Yang 1.118 19,8652 1.118 19,8652 22.209 15 17.9800 -2.107 -9,49
2026-01-05 Williams Charles O 1.566 19,8652 1.566 19,8652 31.109
2025-01-03 Williams Charles O 1.181 17,3700 1.181 17,3700 20.514
2025-01-03 Li Yang 843 17,3700 843 17,3700 14.643
2022-12-14 BLUTT MITCHELL J MD 1.748.750 116.583
2022-12-14 BLUTT MITCHELL J MD 1.297.922 86.528
2022-12-14 BLUTT MITCHELL J MD 450.827 30.055
2022-12-14 BLUTT MITCHELL J MD 1.885.000 125.667
2020-11-18 Consonance Life Sciences 30.000 0,0109 30.000 0,0109 327

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SRZN / Surrozen, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato		 Handle
Dato		 Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris		 Enhed
Pris		 Enheder
Ændret		 Værdi
Ændret (1K)		 Tilbage
Muligheder		 Tilbage
Aktier
2026-04-01 2026-03-31 4 Li Yang SRZN Common Stock G - Gift D -1.666 14.425
2026-03-25 2026-03-24 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 24,6931 53.329 1.317 736.547
2026-03-25 2026-03-24 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 24,6931 53.329 1.317 736.554
2026-03-25 2026-03-23 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 24,8999 7.611 190 683.218
2026-03-25 2026-03-23 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 24,8999 7.612 190 683.225
2026-03-16 2026-03-16 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 24,9857 595 15 675.610
2026-03-16 2026-03-16 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 24,9857 595 15 675.613
2026-03-16 2026-03-13 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 24,8769 17.716 441 675.015
2026-03-16 2026-03-13 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 24,8769 17.717 441 675.018
2026-03-16 2026-03-12 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 24,9851 6.187 155 657.299
2026-03-16 2026-03-12 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 24,9851 6.187 155 657.301
2026-02-13 2026-02-12 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 23,8625 546 13 651.112
2026-02-13 2026-02-12 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 23,8625 547 13 651.114
2026-02-13 2026-02-11 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 23,5750 8.881 209 650.563
2026-02-13 2026-02-11 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 23,5750 8.882 209 650.567
2026-02-03 2026-02-03 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 21,9400 2.177 48 641.682
2026-02-03 2026-02-03 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 21,9400 2.178 48 641.685
2026-02-03 2026-02-02 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 21,3800 365 8 639.505
2026-02-03 2026-02-02 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 21,3800 366 8 639.507
2026-02-03 2026-01-30 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 21,3900 2.135 46 639.140
2026-02-03 2026-01-30 4 TCG Crossover GP II, LLC SRZN Common Stock P - Purchase I 21,3900 2.136 46 639.141
2026-01-28 3 TCG Crossover GP II, LLC SRZN Common Stock I 637.005
2026-01-28 3 TCG Crossover GP II, LLC SRZN Common Stock I 637.005
2026-01-20 2026-01-20 4 COLUMN GROUP III GP, LP By The Column Group III-A, LP SRZN Common Stock P - Purchase I 19,5999 9.568 188 1.016.658
2026-01-20 2026-01-20 4 COLUMN GROUP III GP, LP By The Column Group III, LP SRZN Common Stock P - Purchase I 19,5999 8.484 166 900.292
2026-01-20 2026-01-16 4 COLUMN GROUP III GP, LP By The Column Group III-A, LP SRZN Common Stock P - Purchase I 20,0000 1.358 27 1.007.090
2026-01-20 2026-01-16 4 COLUMN GROUP III GP, LP By The Column Group III, LP SRZN Common Stock P - Purchase I 20,0000 1.204 24 891.808
2026-01-20 2026-01-15 4 COLUMN GROUP III GP, LP By The Column Group III-A, LP SRZN Common Stock P - Purchase I 19,8890 6.303 125 1.005.732
2026-01-20 2026-01-15 4 COLUMN GROUP III GP, LP By The Column Group III, LP SRZN Common Stock P - Purchase I 19,8890 5.590 111 890.604
2026-01-20 2026-01-20 4 Kutzkey Tim By The Column Group III-A, LP SRZN Common Stock P - Purchase I 19,5999 9.568 188 1.016.658
2026-01-20 2026-01-20 4 Kutzkey Tim By The Column Group III, LP SRZN Common Stock P - Purchase I 19,5999 8.484 166 900.292
2026-01-20 2026-01-16 4 Kutzkey Tim By The Column Group III-A, LP SRZN Common Stock P - Purchase I 20,0000 1.358 27 1.007.090
2026-01-20 2026-01-16 4 Kutzkey Tim By The Column Group III, LP SRZN Common Stock P - Purchase I 20,0000 1.204 24 891.808
2026-01-20 2026-01-15 4 Kutzkey Tim By The Column Group III-A, LP SRZN Common Stock P - Purchase I 19,8890 6.303 125 1.005.732
2026-01-20 2026-01-15 4 Kutzkey Tim By The Column Group III, LP SRZN Common Stock P - Purchase I 19,8890 5.590 111 890.604
2026-01-15 2026-01-14 4 COLUMN GROUP III GP, LP By The Column Group III-A, LP SRZN Common Stock P - Purchase I 19,9883 2.927 59 999.429
2026-01-15 2026-01-14 4 COLUMN GROUP III GP, LP By The Column Group III, LP SRZN Common Stock P - Purchase I 19,9883 2.596 52 885.014
2026-01-15 2026-01-13 4 COLUMN GROUP III GP, LP By The Column Group III-A, LP SRZN Common Stock P - Purchase I 19,8041 6.609 131 996.502
2026-01-15 2026-01-13 4 COLUMN GROUP III GP, LP By The Column Group III, LP SRZN Common Stock P - Purchase I 19,8041 5.861 116 882.418
2026-01-15 2026-01-14 4 Kutzkey Tim By The Column Group III-A, LP SRZN Common Stock P - Purchase I 19,9883 2.927 59 999.429
2026-01-15 2026-01-14 4 Kutzkey Tim By The Column Group III, LP SRZN Common Stock P - Purchase I 19,9883 2.596 52 885.014
2026-01-15 2026-01-13 4 Kutzkey Tim By The Column Group III-A, LP SRZN Common Stock P - Purchase I 19,8041 6.609 131 996.502
2026-01-15 2026-01-13 4 Kutzkey Tim By The Column Group III, LP SRZN Common Stock P - Purchase I 19,8041 5.861 116 882.418
2026-01-08 2026-01-06 4 COLUMN GROUP III GP, LP By The Column Group III-A, LP SRZN Common Stock P - Purchase I 19,8872 8.003 159 989.893
2026-01-08 2026-01-06 4 COLUMN GROUP III GP, LP By The Column Group III, LP SRZN Common Stock P - Purchase I 19,8872 7.097 141 876.557
2026-01-08 2026-01-06 4 Kutzkey Tim By The Column Group III-A, LP SRZN Common Stock P - Purchase I 19,8872 8.003 159 989.893
2026-01-08 2026-01-06 4 Kutzkey Tim By The Column Group III, LP SRZN Common Stock P - Purchase I 19,8872 7.097 141 876.557
2026-01-06 2026-01-05 4 Li Yang SRZN Common Stock S - Sale D 19,8652 -1.118 -22 16.091
2026-01-06 2026-01-02 4 Li Yang SRZN Common Stock M - Exercise D 2.500 17.209
2026-01-06 2026-01-05 4 Williams Charles O SRZN Common Stock S - Sale D 19,8652 -1.566 -31 12.982
2026-01-06 2026-01-02 4 Williams Charles O SRZN Common Stock M - Exercise D 3.500 14.548
2025-12-16 2025-12-15 4 Li Yang SRZN Common Stock A - Award D 8,1100 1.666 14 14.709
2025-12-16 2025-12-15 4 Williams Charles O SRZN Common Stock A - Award D 8,1100 1.666 14 11.048
2025-12-16 2025-12-15 4 Parker Craig C SRZN Common Stock A - Award D 8,1100 1.553 13 8.577
2025-12-08 2025-12-05 4 Kutzkey Tim By The Column Group III-A, LP SRZN Common Stock P - Purchase I 19,5409 16.381 320 981.890
2025-12-08 2025-12-05 4 Kutzkey Tim By The Column Group III, LP SRZN Common Stock P - Purchase I 19,5409 14.503 283 869.460
2025-12-08 2025-12-04 4 Kutzkey Tim By The Column Group III-A, LP SRZN Common Stock P - Purchase I 17,3470 2.791 48 965.509
2025-12-08 2025-12-04 4 Kutzkey Tim By The Column Group III, LP SRZN Common Stock P - Purchase I 17,3470 2.475 43 854.957
2025-12-08 2025-12-05 4 COLUMN GROUP III GP, LP By The Column Group III-A, LP SRZN Common Stock P - Purchase I 19,5409 16.381 320 981.890
2025-12-08 2025-12-05 4 COLUMN GROUP III GP, LP By The Column Group III, LP SRZN Common Stock P - Purchase I 19,5409 14.503 283 869.460
2025-12-08 2025-12-04 4 COLUMN GROUP III GP, LP By The Column Group III-A, LP SRZN Common Stock P - Purchase I 17,3470 2.791 48 965.509
2025-12-08 2025-12-04 4 COLUMN GROUP III GP, LP By The Column Group III, LP SRZN Common Stock P - Purchase I 17,3470 2.475 43 854.957
2025-12-02 2025-11-13 4 Kutzkey Tim By The Column Group III-A, LP SRZN Common Stock P - Purchase I 12,6500 167.307 2.116 962.718
2025-12-02 2025-11-13 4 Kutzkey Tim By The Column Group III, LP SRZN Common Stock P - Purchase I 12,6500 148.150 1.874 852.482
2025-11-17 2025-11-13 4 COLUMN GROUP III GP, LP By The Column Group III-A, LP SRZN Common Stock P - Purchase I 12,6500 167.307 2.116 962.718
2025-11-17 2025-11-13 4 COLUMN GROUP III GP, LP By The Column Group III, LP SRZN Common Stock P - Purchase I 12,6500 148.150 1.874 852.482
2025-06-16 2025-06-13 4 Li Yang SRZN Common Stock A - Award D 8,0600 400 3 13.043
2025-06-16 2025-06-13 4 Williams Charles O SRZN Common Stock A - Award D 8,0600 400 3 9.382
2025-06-16 2025-06-13 4 Parker Craig C SRZN Common Stock A - Award D 8,0600 400 3 7.024
2025-03-28 3 Kutzkey Tim By The Column Group III, LP SRZN Common Stock I 704.332
2025-03-28 3 Kutzkey Tim By The Column Group Opportunity III, LP SRZN Common Stock I 344.827
2025-03-28 3 Kutzkey Tim By The Column Group III-A, LP SRZN Common Stock I 795.411
2025-03-28 2025-03-26 4 COLUMN GROUP III GP, LP By The Column Group Opportunity III, LP SRZN Common Stock P - Purchase I 11,6000 344.827 4.000 344.827
2025-03-28 2025-03-26 4 COLUMN GROUP III GP, LP By The Column Group III-A, LP SRZN Common Stock P - Purchase I 11,6000 365.769 4.243 795.411
2025-03-28 2025-03-26 4 COLUMN GROUP III GP, LP By The Column Group III, LP SRZN Common Stock P - Purchase I 11,6000 323.886 3.757 704.332
2025-01-06 2025-01-03 4 Li Yang SRZN Common Stock S - Sale D 17,3700 -843 -15 13.345
2025-01-06 2025-01-02 4 Li Yang SRZN Common Stock M - Exercise D 2.500 14.188
2025-01-06 2025-01-03 4 Williams Charles O SRZN Common Stock S - Sale D 17,3700 -1.181 -21 8.982
2025-01-06 2025-01-02 4 Williams Charles O SRZN Common Stock M - Exercise D 3.500 10.163
2024-06-18 2024-06-14 4 Li Yang SRZN Common Stock A - Award D 5,6700 400 2 10.888
2024-06-18 2024-06-14 4 Williams Charles O SRZN Common Stock A - Award D 5,6700 400 2 5.863
2024-06-18 2024-06-14 4 Parker Craig C SRZN Common Stock A - Award D 5,6700 400 2 5.824
2024-04-17 2024-04-04 4/A COLUMN GROUP III GP, LP By The Column Group III-A, LP SRZN Common Stock P - Purchase I 15,5000 102.651 1.591 326.992
2024-04-17 2024-04-04 4/A COLUMN GROUP III GP, LP By The Column Group III, LP SRZN Common Stock P - Purchase I 15,5000 90.897 1.409 289.549
2024-04-17 2024-04-04 4/A Kutzkey Tim By The Column Group III-A, LP SRZN Common Stock P - Purchase I 15,5000 102.651 1.591 326.992
2024-04-17 2024-04-04 4/A Kutzkey Tim By The Column Group III, LP SRZN Common Stock P - Purchase I 15,5000 90.897 1.409 289.549
2024-04-08 2024-04-04 4 Williams Charles O SRZN Common Stock P - Purchase D 1.474 1.474
2024-04-08 2024-04-04 4 Parker Craig C SRZN Common Stock P - Purchase D 1.474 1.474
2024-04-08 2024-04-04 4 COLUMN GROUP III GP, LP By The Column Group III-A, LP SRZN Common Stock P - Purchase I 15,5000 102.651 1.591 332.885
2024-04-08 2024-04-04 4 COLUMN GROUP III GP, LP By The Column Group III, LP SRZN Common Stock P - Purchase I 15,5000 90.897 1.409 294.767
2024-04-08 2024-04-04 4 Kutzkey Tim By The Column Group III-A, LP SRZN Common Stock P - Purchase I 15,5000 102.651 1.591 332.885
2024-04-08 2024-04-04 4 Kutzkey Tim By The Column Group III, LP SRZN Common Stock P - Purchase I 15,5000 90.897 1.409 294.767
2023-12-18 2023-12-15 4 Williams Charles O SRZN Common Stock A - Award D 5,6700 2.085 12 2.085
2023-12-18 2023-12-15 4 Li Yang SRZN Common Stock A - Award D 5,6700 2.085 12 2.085
2023-12-18 2023-12-15 4 Parker Craig C SRZN Common Stock A - Award D 5,6700 2.046 12 2.046
2023-08-23 3 Li Yang SRZN Common Stock D 121.524
2023-08-23 3 Li Yang SRZN Common Stock I 10.538
2023-06-20 2023-06-15 4 Yeh Wen-Chen SRZN Common Stock A - Award D 0,3800 17.638 7 27.216
2023-06-20 2023-06-15 4 Parker Craig C SRZN Common Stock A - Award D 0,3800 25.000 10 34.578
2023-06-20 2023-06-15 4 Williams Charles O SRZN Common Stock A - Award D 0,3800 25.000 10 34.578
2022-12-19 2022-12-15 4 Yeh Wen-Chen SRZN Common Stock A - Award D 0,4100 9.578 4 229.138
2022-12-19 2022-12-15 4 Parker Craig C SRZN Common Stock A - Award D 0,4100 9.578 4 9.578
2022-12-19 2022-12-15 4 Vanhove Geertrui SRZN Common Stock A - Award D 0,4100 9.578 4 32.412
2022-12-19 2022-12-15 4 Williams Charles O SRZN Common Stock A - Award D 0,4100 9.578 4 9.578
2022-12-15 2022-12-14 4 BLUTT MITCHELL J MD By Consonance Life Sciences, LLC SRZN Common Stock S - Sale I -1.885.000 0
2022-12-15 2022-12-14 4 BLUTT MITCHELL J MD By Managed Account SRZN Common Stock S - Sale I -450.827 0
2022-12-15 2022-12-14 4 BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP SRZN Common Stock S - Sale I -1.297.922 0
2022-12-15 2022-12-14 4 BLUTT MITCHELL J MD By Consonance Capital Master Account LP SRZN Common Stock S - Sale I -1.748.750 0
2022-03-03 2022-03-01 4 Yeh Wen-Chen SRZN Option (right to buy) A - Award D 3,11 125.000 125.000
2022-03-03 2022-03-01 4 Parker Craig C SRZN Stock Option (right to buy) A - Award D 3,11 370.000 370.000
2022-03-03 2022-03-01 4 Williams Charles O SRZN Option (right to buy) A - Award D 3,11 125.000 125.000
2022-03-03 2022-03-01 4 Vanhove Geertrui SRZN Option Grant (right to buy) A - Award D 3,11 3,1100 125.000 389 125.000
2021-08-16 3 COLUMN GROUP III, LP By The Column Group III, LP SRZN Common Stock I 4.343.245
2021-08-16 3 COLUMN GROUP III, LP By The Column Group III-A, LP SRZN Common Stock I 4.904.884
2021-08-16 3 Kutzkey Tim By The Column Group III-A, LP SRZN Common Stock I 4.904.884
2021-08-16 3 Kutzkey Tim By The Column Group III, LP SRZN Common Stock I 4.343.245
2021-08-16 2021-08-12 4 Parker Craig C SRZN Stock Option (right to buy) A - Award D 10,25 183.335 183.335
2021-08-16 2021-08-12 4 Vanhove Geertrui SRZN Employee Stock Option (right to buy) A - Award D 10,25 36.647 36.647
2021-08-16 3 Vanhove Geertrui SRZN Common Stock D 22.834
2021-08-16 2021-08-12 4 Williams Charles O SRZN Employee Stock Option (right to buy) A - Award D 10,25 14.597 14.597
2021-08-16 3 WOODHOUSE DAVID J SRZN Common Stock D 35.129
2021-08-16 3 Rothenberg Mace SRZN Common Stock D 35.129
2021-08-16 3 Haak-Frendscho Mary SRZN Common Stock D 35.129
2021-08-16 3 Berkenblit Anna SRZN Common Stock D 35.129
2021-08-16 3 Lin Shao-Lee SRZN Common Stock D 35.129
2021-08-16 3 Yeh Wen-Chen SRZN Common Stock D 219.560
2021-08-16 3 CHAI CHRISTOPHER Y SRZN Common Stock D 35.129
2021-08-13 2021-08-11 4 Consonance Life Sciences SRZN Warrants A - Award I 11,50 -144.667 144.667
2021-08-13 2021-08-11 4 Consonance Life Sciences SRZN Warrants D - Sale to Issuer I 11,50 -144.667 0
2021-08-13 2021-08-11 4 Consonance Life Sciences SRZN Common Stock A - Award I 1.451.000 1.885.000
2021-08-13 2021-08-11 4 Consonance Life Sciences SRZN Common Stock A - Award I 434.000 434.000
2021-08-13 2021-08-11 4 Consonance Life Sciences SRZN Class B Ordinary Shares D - Sale to Issuer I -1.451.000 0
2021-08-13 2021-08-11 4 Consonance Life Sciences SRZN Class B Ordinary Shares J - Other I -759.000 1.451.000
2021-08-13 2021-08-11 4 Consonance Life Sciences SRZN Class A Ordinary Shares D - Sale to Issuer I -434.000 0
2021-08-13 2021-08-11 4 Jarrett Jennifer SRZN Class B Ordinary Shares D - Sale to Issuer D -30.000 0
2021-08-13 2021-08-11 4 Jarrett Jennifer SRZN Common Stock A - Award D 30.000 30.000
2021-08-13 2021-08-11 4 Santel Donald J SRZN Class B Ordinary Shares D - Sale to Issuer D -30.000 0
2021-08-13 2021-08-11 4 Santel Donald J SRZN Common Stock A - Award D 30.000 30.000
2021-08-13 2021-08-11 4 Soffer Benny SRZN Warrants A - Award I 11,50 -144.667 144.667
2021-08-13 2021-08-11 4 Soffer Benny SRZN Warrants D - Sale to Issuer I 11,50 -144.667 0
2021-08-13 2021-08-11 4 Soffer Benny SRZN Common Stock A - Award I 1.451.000 1.885.000
2021-08-13 2021-08-11 4 Soffer Benny SRZN Common Stock A - Award I 434.000 434.000
2021-08-13 2021-08-11 4 Soffer Benny SRZN Class B Ordinary Shares D - Sale to Issuer I -1.451.000 0
2021-08-13 2021-08-11 4 Soffer Benny SRZN Class B Ordinary Shares J - Other I -759.000 1.451.000
2021-08-13 2021-08-11 4 Soffer Benny SRZN Class A Ordinary Shares D - Sale to Issuer I -434.000 0
2021-08-13 2021-08-11 4 Haqq Christopher SRZN Class B Ordinary Shares D - Sale to Issuer D -30.000 0
2021-08-13 2021-08-11 4 Haqq Christopher SRZN Common Stock A - Award D 30.000 30.000
2021-08-13 2021-08-11 4 Livingston Kevin Harold SRZN Warrants A - Award I 11,50 -144.667 144.667
2021-08-13 2021-08-11 4 Livingston Kevin Harold SRZN Warrants D - Sale to Issuer I 11,50 -144.667 0
2021-08-13 2021-08-11 4 Livingston Kevin Harold SRZN Common Stock A - Award I 1.451.000 1.885.000
2021-08-13 2021-08-11 4 Livingston Kevin Harold SRZN Common Stock A - Award I 434.000 434.000
2021-08-13 2021-08-11 4 Livingston Kevin Harold SRZN Class B Ordinary Shares D - Sale to Issuer I -1.451.000 0
2021-08-13 2021-08-11 4 Livingston Kevin Harold SRZN Class B Ordinary Shares J - Other I -759.000 1.451.000
2021-08-13 2021-08-11 4 Livingston Kevin Harold SRZN Class A Ordinary Shares D - Sale to Issuer I -434.000 0
2021-08-13 2021-08-11 4 BLUTT MITCHELL J MD By Managed Account SRZN Warrants (right to buy) A - Award I 11,50 107.309 150.275
2021-08-13 2021-08-11 4 BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP SRZN Warrants (right to buy) A - Award I 11,50 308.940 432.640
2021-08-13 2021-08-11 4 BLUTT MITCHELL J MD By Consonance Capital Master Account LP SRZN Warrants (right to buy) A - Award I 11,50 416.250 582.917
2021-08-13 2021-08-11 4 BLUTT MITCHELL J MD By Managed Account SRZN Warrants (right to buy) P - Purchase I 11,50 42.966 42.966
2021-08-13 2021-08-11 4 BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP SRZN Warrants (right to buy) P - Purchase I 11,50 123.700 123.700
2021-08-13 2021-08-11 4 BLUTT MITCHELL J MD By Consonance Capital Master Account LP SRZN Warrants (right to buy) P - Purchase I 11,50 166.667 166.667
2021-08-13 2021-08-11 4 BLUTT MITCHELL J MD By Managed Account SRZN Common Stock A - Award I 321.928 450.828
2021-08-13 2021-08-11 4 BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP SRZN Common Stock A - Award I 926.822 1.297.922
2021-08-13 2021-08-11 4 BLUTT MITCHELL J MD By Consonance Capital Master Account LP SRZN Common Stock A - Award I 1.248.750 1.748.750
2021-08-13 2021-08-11 4 BLUTT MITCHELL J MD By Managed Account SRZN Common Stock A - Award I 128.900 128.900
2021-08-13 2021-08-11 4 BLUTT MITCHELL J MD By Managed Account SRZN Class A Ordinary Shares D - Sale to Issuer I -128.900 0
2021-08-13 2021-08-11 4 BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP SRZN Common Stock A - Award I 371.100 371.100
2021-08-13 2021-08-11 4 BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP SRZN Class A Ordinary Shares D - Sale to Issuer I -371.100 0
2021-08-13 2021-08-11 4 BLUTT MITCHELL J MD By Consonance Capital Master Account LP SRZN Common Stock A - Award I 500.000 500.000
2021-08-13 2021-08-11 4 BLUTT MITCHELL J MD By Consonance Capital Master Account LP SRZN Class A Ordinary Shares D - Sale to Issuer I -500.000 0
2021-05-19 2020-11-23 4/A Consonance Life Sciences CHFW Warrant A - Award D 11,50 136.667 136.667
2021-05-19 2020-11-23 4/A Consonance Life Sciences CHFW Class A Ordinary Shares A - Award D 410.000 410.000
2021-05-19 2020-11-18 4/A Consonance Life Sciences CHFW Class B Ordinary Shares S - Sale D 0,0109 -30.000 -0 2.210.000
2021-05-19 2020-11-18 4/A Consonance Life Sciences CHFW Class B Ordinary Shares S - Sale D 0,0109 -30.000 -0 2.210.000
2021-05-19 2020-11-18 4/A Consonance Life Sciences CHFW Class B Ordinary Shares S - Sale D 0,0109 -30.000 -0 2.240.000
2021-05-19 2020-11-10 4/A Consonance Life Sciences CHFW Class B Ordinary Shares D - Sale to Issuer D -575.000 2.300.000
2021-05-19 2020-10-08 4/A Consonance Life Sciences CHFW Class B Ordinary Shares D - Sale to Issuer D -718.750 2.875.000
2021-05-19 2020-09-04 4/A Consonance Life Sciences CHFW Class B Ordinary Shares A - Award D 0,0070 3.593.750 25 3.593.750
2021-05-19 2020-12-01 4/A Soffer Benny CHFW Warrant A - Award I 11,50 8.000 144.667
2021-05-19 2020-12-01 4/A Soffer Benny CHFW Class A Ordinary Shares A - Award I 24.000 434.000
2021-05-19 2020-11-23 4/A BLUTT MITCHELL J MD CHFW Warrant A - Award I 11,50 136.667 136.667
2021-05-19 2020-11-23 4/A BLUTT MITCHELL J MD CHFW Class A Ordinary Shares A - Award I 410.000 410.000
2021-05-19 2020-11-18 4/A BLUTT MITCHELL J MD CHFW Class B Ordinary Shares S - Sale I 0,0109 -30.000 -0 2.210.000
2021-05-19 2020-11-18 4/A BLUTT MITCHELL J MD CHFW Class B Ordinary Shares S - Sale I 0,0109 -30.000 -0 2.210.000
2021-05-19 2020-11-18 4/A BLUTT MITCHELL J MD CHFW Class B Ordinary Shares S - Sale I 0,0109 -30.000 -0 2.240.000
2021-05-19 2020-11-10 4/A BLUTT MITCHELL J MD CHFW Class B Ordinary Shares D - Sale to Issuer I -575.000 2.300.000
2021-05-19 2020-10-08 4/A BLUTT MITCHELL J MD CHFW Class B Ordinary Shares D - Sale to Issuer I -718.750 2.875.000
2021-05-19 2020-09-04 4/A BLUTT MITCHELL J MD CHFW Class B Ordinary Shares A - Award I 0,0070 3.593.750 25 3.593.750
2021-05-19 2020-11-23 4/A Soffer Benny CHFW Warrant A - Award I 11,50 136.667 136.667
2021-05-19 2020-11-23 4/A Soffer Benny CHFW Class A Ordinary Shares A - Award I 410.000 410.000
2021-05-19 2020-11-18 4/A Soffer Benny CHFW Class B Ordinary Shares S - Sale I 0,0109 -30.000 -0 2.210.000
2021-05-19 2020-11-18 4/A Soffer Benny CHFW Class B Ordinary Shares S - Sale I 0,0109 -30.000 -0 2.210.000
2021-05-19 2020-11-18 4/A Soffer Benny CHFW Class B Ordinary Shares S - Sale I 0,0109 -30.000 -0 2.240.000
2021-05-19 2020-11-10 4/A Soffer Benny CHFW Class B Ordinary Shares D - Sale to Issuer I -575.000 2.300.000
2021-05-19 2020-10-08 4/A Soffer Benny CHFW Class B Ordinary Shares D - Sale to Issuer I -718.750 2.875.000
2021-05-19 2020-09-04 4/A Soffer Benny CHFW Class B Ordinary Shares A - Award I 0,0070 3.593.750 25 3.593.750
2021-05-19 2020-12-01 4/A Consonance Life Sciences CHFW Warrant A - Award D 11,50 8.000 144.667
2021-05-19 2020-12-01 4/A Consonance Life Sciences CHFW Class A Ordinary Shares A - Award D 24.000 434.000
2021-05-19 2020-12-01 4/A Livingston Kevin Harold CHFW Warrant A - Award I 11,50 8.000 144.667
2021-05-19 2020-12-01 4/A Livingston Kevin Harold CHFW Class A Ordinary Shares A - Award I 24.000 434.000
2021-05-19 2020-11-23 4/A Livingston Kevin Harold CHFW Warrant A - Award I 11,50 136.667 136.667
2021-05-19 2020-11-23 4/A Livingston Kevin Harold CHFW Class A Ordinary Shares A - Award I 410.000 410.000
2021-05-19 2020-11-18 4/A Livingston Kevin Harold CHFW Class B Ordinary Shares S - Sale I 0,0109 -30.000 -0 2.210.000
2021-05-19 2020-11-18 4/A Livingston Kevin Harold CHFW Class B Ordinary Shares S - Sale I 0,0109 -30.000 -0 2.210.000
2021-05-19 2020-11-18 4/A Livingston Kevin Harold CHFW Class B Ordinary Shares S - Sale I 0,0109 -30.000 -0 2.240.000
2021-05-19 2020-11-10 4/A Livingston Kevin Harold CHFW Class B Ordinary Shares D - Sale to Issuer I -575.000 2.300.000
2021-05-19 2020-10-08 4/A Livingston Kevin Harold CHFW Class B Ordinary Shares D - Sale to Issuer I -718.750 2.875.000
2021-05-19 2020-09-04 4/A Livingston Kevin Harold CHFW Class B Ordinary Shares A - Award I 0,0070 3.593.750 25 3.593.750
2021-05-19 2020-12-01 4/A BLUTT MITCHELL J MD CHFW Warrant A - Award I 11,50 8.000 144.667
2021-05-19 2020-12-01 4/A BLUTT MITCHELL J MD CHFW Class A Ordinary Shares A - Award I 24.000 434.000
2021-05-19 3/A BLUTT MITCHELL J MD Consonance Life Sciences, LLC CHFW Class B Ordinary Shares I 2.210.000
2021-05-19 3/A Soffer Benny Consonance Life Sciences, LLC CHFW Class B Ordinary Shares I 2.210.000
2021-05-19 3/A Livingston Kevin Harold Consonance Life Sciences, LLC CHFW Class B Ordinary Shares I 2.210.000
2021-05-19 3/A Consonance Life Sciences CHFW Class B Ordinary Shares D 2.210.000
2020-12-04 2020-11-23 4 BLUTT MITCHELL J MD By Managed Account CHFW Class A Ordinary Shares P - Purchase I 128.900 128.900
2020-12-04 2020-11-23 4 BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP CHFW Class A Ordinary Shares P - Purchase I 371.100 371.100
2020-12-04 2020-11-23 4 BLUTT MITCHELL J MD By Consonance Capital Master Account, LP CHFW Class A Ordinary Shares P - Purchase I 500.000 500.000
2020-12-03 2020-12-01 4 Livingston Kevin Harold CHFW Warrant P - Purchase I 11,50 8.000 144.667
2020-12-03 2020-12-01 4 Livingston Kevin Harold CHFW Class A Ordinary Shares P - Purchase I 24.000 434.000
2020-12-03 2020-12-01 4 Consonance Life Sciences CHFW Warrant P - Purchase D 11,50 8.000 144.667
2020-12-03 2020-12-01 4 Consonance Life Sciences CHFW Class A Ordinary Shares P - Purchase D 24.000 434.000
2020-12-03 2020-12-01 4 Soffer Benny CHFW Warrant P - Purchase I 11,50 8.000 144.667
2020-12-03 2020-12-01 4 Soffer Benny CHFW Class A Ordinary Shares P - Purchase I 24.000 434.000
2020-12-03 2020-12-01 4 BLUTT MITCHELL J MD CHFW Warrant P - Purchase I 11,50 8.000 144.667
2020-12-03 2020-12-01 4 BLUTT MITCHELL J MD CHFW Class A Ordinary Shares P - Purchase I 24.000 434.000
2020-11-25 2020-11-23 4 Consonance Life Sciences CHFW Warrant P - Purchase D 11,50 136.667 136.667
2020-11-25 2020-11-23 4 Consonance Life Sciences CHFW Class A Ordinary Shares P - Purchase D 410.000 410.000
2020-11-25 2020-11-23 4 Soffer Benny CHFW Warrant P - Purchase I 11,50 136.667 136.667
2020-11-25 2020-11-23 4 Soffer Benny CHFW Class A Ordinary Shares P - Purchase I 410.000 410.000
2020-11-25 2020-11-23 4 BLUTT MITCHELL J MD CHFW Warrant P - Purchase I 11,50 136.667 136.667
2020-11-25 2020-11-23 4 BLUTT MITCHELL J MD CHFW Class A Ordinary Shares P - Purchase I 410.000 410.000
2020-11-25 2020-11-23 4 Livingston Kevin Harold CHFW Warrant P - Purchase I 11,50 136.667 136.667
2020-11-25 2020-11-23 4 Livingston Kevin Harold CHFW Class A Ordinary Shares P - Purchase I 410.000 410.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista

© 2015-2026 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.

About Fintel
Features
Explore
Help Center